Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

Biomedicines - Switzerland
doi 10.3390/biomedicines8020022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG